Company news
Wellnex Life Ltd (ASX:WNX) news
Wellnex Life Ltd news releases on 6ix. Latest, Aug 31, 2026: Wellnex Life Releases FY26 Annual Report
Press releases & updates
Wellnex Life Releases FY26 Annual Report
August 31, 2026
Sale of Pain Away for up to A$21.3 million
August 6, 2026
Appendix 4C and Quarterly Report for Jun 2026 Quarter
July 31, 2026
Appendix 4C and Quarterly Report for Mar 2026 Quarter
April 30, 2026
Extension of Loan Repayment
April 22, 2026
Wellnex Life Releases Half Year Report
February 26, 2026
Half Yearly Report and Accounts
February 26, 2026
Company Update
February 9, 2026
Appendix 4C and Quarterly Report for Dec 2025 Quarter
January 28, 2026
Market Update
January 15, 2026
Trading Update
December 16, 2025
Resignation of CEO and Loan Repayment
October 20, 2025
Appendix 4C and Quarterly Report for Sep 2025 Quarter
October 19, 2025
Wellnex Life Releases FY25 Annual Report
September 30, 2025
Expanded Financing Facility
September 18, 2025
Wellnex Releases FY25 Appendix 4E & Preliminary Report
August 29, 2025
Appendix 4E Preliminary Final Report
August 29, 2025
Resignation of Joint CEO
August 15, 2025
Appendix 4C and Quarterly Report for Jun 2025 Quarter
July 31, 2025
Response to ASX Query
May 29, 2025
Retraction of Announcement
May 29, 2025
Reinstatement to Quotation
May 29, 2025
Suspension from Quotation
May 26, 2025
Board and Management Changes
May 5, 2025
Appointment of Powermed Plus as UK Distributor
April 9, 2025
Appendix 4C and Quarterly Report for Mar 2025 Quarter
April 8, 2025
Commencement of Trading on LSE AIM
March 23, 2025
Pain Away Deferred Consideration Fully Satisfied
March 21, 2025
Wellnex Publishes Admission Document to LSE AIM
March 19, 2025
Trading Halt
March 17, 2025
Trading and UK IPO Update
March 14, 2025
Entitlement Offer Results
March 5, 2025
Director Participation in the Entitlement Offer
February 20, 2025
Wellnex Secures $14.3m Conditional Binding Commitments
February 19, 2025
Wellnex Life Receives an Initial A$9 million Commitments
February 13, 2025
Entitlement Offer Booklet
February 9, 2025
Wellnex Life Launches Entitlement Offer
February 9, 2025
Wellnex obtains Market Authorisation with TGA
February 3, 2025
Appendix 4C and Quarterly Report for Dec 2024 Quarter
January 31, 2025
Pain Away Update
January 20, 2025
Completion of Placement
December 20, 2024
Update on Pain Away Deferred Consideration
November 4, 2024
Appendix 4C and Quarterly Report for Sep 2024 Quarter
October 31, 2024
Update on LSE Dual Listing
October 23, 2024
Wellnex Life Releases FY24 Annual Report
September 30, 2024
Appointment of Chair
September 9, 2024
Wellnex Releases FY24 Appendix 4E & Preliminary Report
August 30, 2024
Notice of Extraordinary General Meeting/Proxy Form
August 28, 2024
Launch of Medicinal Cannabis Brand Wellness Life for SAS
August 15, 2024
Further Update to Announcement on Opening Order from the UK
August 15, 2024